GUILFORD, Conn., March 18 /PRNewswire/ -- RainDance Technologies, Inc., a developer of NanoReactor droplet-based microfluidic technology, today announced the appointment of Stephen E. Becker as Vice President, Commercial Officer, effective immediately.
"Mr. Becker will be responsible for continuing the growth of the company's commercial operations as it prepares for the launch of its first life science offering," said Chris McNary, President and Chief Executive Officer, RainDance Technologies. "These duties will include the continued development of the sales channels, leading customer service and support programs, and development of the strategic marketing plan."
The RainDance platform combines emulsion-based droplets and microfluidics to enable a host of existing applications in the company's nano-scale format, including genomic analysis, cell-based assays, and single molecule detection. Samples such as cells, nucleic acids, proteins, beads, and chemical compounds are encapsulated in individual micron-sized droplets on assay-specific microfludic chips. Since each droplet is the equivalent of a well in a microtiter plate, the RainDance platform can process and analyze up to 10,000 samples per second with unparalleled accuracy.
Becker joins RainDance from Agilent Technologies, where he served as
Senior Sales Manager in the company's Americas Field Operations. There, he
led the commercial introduction of novel genetic and epigenetic microarray
assays that achieved over 20% growth rates in 2006 and 2007 in the research
and molecular diagnostics markets. At GE Healthcare (formerly Amersham
Pharmacia Biotech), Becker held several senior management assignments,
including Director, Gene and Protein Discovery, and Director, Business
Support. He also held sales management positions at Spectrum Chemical
Manufacturing Corporation and Curtin Matheson Scientific, Inc. Becker
received a bachelor's degree in biology from St. Mary's College of
|SOURCE RainDance Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved